Evaluation of the Pharmacokinetics of Dapagliflozin in Patients With Chronic Kidney Disease With or Without Type 2 Diabetes Mellitus.
慢性腎臟病患者合併或不合併2型糖尿病的 Dapagliflozin 藥物動力學評估。
J Clin Pharmacol 2023-06-01
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial.
Dapagliflozin在慢性腎臟疾病中的影響,有無其他心血管藥物:DAPA-CKD試驗。
J Am Heart Assoc 2023-09-12
Clinical Efficacy of Dapagliflozin in the Treatment of Patients with Diabetic Nephropathy and Its Effect on Proteinuria Level.
糖尿病腎病患者治療中Dapagliflozin的臨床療效及其對蛋白尿水平的影響。
Diabetes Metab Syndr Obes 2023-07-29
Short-Term Dapagliflozin Administration in Autosomal Dominant Polycystic Kidney Disease-A Retrospective Single-Arm Case Series Study.
在常染色體優勢多囊腎病中短期使用達帕格列醇的回顧性單臂病例系列研究。
J Clin Med 2023-10-20
Additional renoprotective effect of the SGLT2 inhibitor dapagliflozin in a patient with ADPKD receiving tolvaptan treatment.
SGLT2 抑制劑 dapagliflozin 在接受 tolvaptan 治療的ADPKD患者中具有額外的腎保護作用。
CEN Case Rep 2024-03-18
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
慢性腎臟病中達帕格列酮的長期影響:時間至事件分析。
Nephrol Dial Transplant 2024-05-11
Impact of Dapagliflozin Adjunctive Therapy on the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease Stages 2-5: A systematic review and meta-analysis.
Dapagliflozin 輔助療法對於 2 型糖尿病及慢性腎病 2-5 期患者慢性腎病進展的影響:系統性回顧與統合分析。
Sultan Qaboos Univ Med J 2024-09-05